Scancell Share Discussion Threads

[inanaco] 05/12/2024 08:45

The good news Lindy emailed me back regarding the reasons why we are running another cohort and its all about putting the best foot forward, if ISCIB1 was an issue they would not run another trial.

and if you actually take the time to read the RNS you will see the direction we are going has changed, with the change of CEO and up to date data which includes exactly what is being predicted affecting funding going forward. Most of the tax rises do not take effect until next April but its already chilling the economy.

but ... the registrational trial has been delayed they are going for deals first on ISCIB1

and they are prepared to release data on Simon 1 modi1 19 patients

[nigelpm] 05/12/2024 08:42

ha ha - excepting some uplift in NI which won't make a lot of difference government pretty irrelevant

[rogerbridge] 05/12/2024 08:41

Some would have bought on that initial spike yesterday morning, to announce an after hours placing is not ethical. Then again, it’s the way this market works.
My only consolation is that the board is in a stronger position to negotiate with a major, with funds in the bank.
I will remain invested and will wait to see the share price reaction before deciding on the offer.

[2tyke] 05/12/2024 08:41

Lol...turning nasty on LSE.
The bully's like TF are out again !
At least EE is used to being scammed.
Inane prefers politics now...he knows nought about that either..lol

[ivyspivey] 05/12/2024 08:34

Of course it is complicated but you are blaming Labour for SCLP having to raise money at these levels.
Will let others decide if your reasoning is sound.

[inanaco] 05/12/2024 08:30

its way more complicated than you think ... but consider the backdrop


James Dyson: Reeves’s Budget is ‘an egregious act of self-harm’
British inventor says Chancellor’s tax changes will ‘kill entrepreneurship and stunt growth’

when we would have run out of money next year .... so will the economy !

people think i post this stuff about labour because of politics when actually it has a direct effect on Scancell

so thank Ivy for the current raise .. the grubby socialist

[sci102] 05/12/2024 08:30

It is Lindy that has been lying to you all this time you fool!

What happened to the "banked"?
What happened to "iscb1+is the bee's knees"? They now said it needs to be better, same is not enough?
What happened to patients have been waiting for iscib1+?
What happened to results by end of 2024 when it was perfectly clear it could not happen?
Not even an exhaustive list

[nigelpm] 05/12/2024 08:25

They needed cash - beggars can't be choosers - this will have been worked over weeks - probably before Phil even joined.

[plasybryn] 05/12/2024 08:24

Very upset by yesterdays behaviour. Who advised them to act in that way should be sacked. But the Co is to blame for agreeing to that. I'm surprised at Lindy unless she was over-ruled. I just can't see the point in undermining trust when it surely wasn't necessary. Very odd imo. Look at the Amarok Resources raise yesterday. That is how to do it.

[2tyke] 05/12/2024 08:18

Really poor investments these little biotechs...steer clear unless your a dreamer or benefactor.
Yes....the usual reaction to an RNS.
The market is a place of irony....and...

[talais] 05/12/2024 08:10

Pyc, doing well lots of contracts coming in

[2tyke] 05/12/2024 08:01

Ouch....poor old inane.
Sympathy dude...

[2tyke] 05/12/2024 07:59

On a happy note....hearty congrats to markingtime who spotted Bitcoin was about to soar over $100,000
At least someone on here is smart !

[nigelpm] 05/12/2024 07:46

Usually means they are struggling to fill...

[ivyspivey] 05/12/2024 07:44

Yep Nigel surprised there was non7am news.Will have to wait for detail andvtgst will determine how to play this imo.
Yes SCI cresting aspects of BoD behaviour have surprised certain folk on here who expected more candid communication

[ivyspivey] 05/12/2024 07:34

Morning Ruck,
Still not seen any news of interest in raise so will have to wait to assess.
As you said those that dismiss funding concerns should not be listened to unless you want to lose a lot of money but remember the names.
How can anyone with 1.68 m shares be happy with losing the cost of two car oarks overnight.Just shows how out of touch they are.
As you say the raise does not even take them to confirming pivotal trials so only limited upside unless you wait another 5 years

[nigelpm] 05/12/2024 07:33

Agreed ruck. Some truly laughable folk have been made to look very silly here. I notice no bookbuild RNS either. Demand probably not that strong.

[ruckrover] 05/12/2024 07:29

Inan, "the good news we don't have to listen to dilution drivel going forward "Turns out that what you think is drivel was spot on. Perhaps you need to listen more? Still, ignorance is bliss as they say. Hilarious that my past comments "dilution cannot be ruled out as a possibility" were greeted with such derision lol. I wouldn't rule out more to come (not for a year or so)

[sci102] 05/12/2024 07:23

Doesn't necessarily work this way Ivy. There are better ways that work best for the company and shareholders. Nove of them involves narcisistic behaviour from the management though.

And from the point of view of the shareholder, none of them includes taking management's word for a fact

[chilltime] 05/12/2024 07:21

TF

With 5 Glymabs and all probably going into deals, then in the current form you end up with 5 initial up fronts then 15 phase 1, phase 2 etc, as each typically involves three potential therapy types.

SC134 should be a completely different ball game, due to the interest, efficacy, safety and a 250k per year patient population with an unmet need.

[ivyspivey] 05/12/2024 07:21

Yep Loggie a big ouch and a lesson to be learned by how this game works but I fear their arrogance surpasses their capacity to think beyond their own huge ego.

[chilltime] 05/12/2024 07:17

The only ouch is the timing post a good news item.

In reality about a 10% dilution, with a forecast of the runway out to H2 2026.

That gives much more time for discussions on Glymab deals especially SC134.

Compared to the typical AIM raises and dilution over the last year it’s a non event, many have not been able to attract investment at all (liquidated) others at huge discount and dilution.

I suspect participants will include previous fund backers in the last raise, none of which are typical AIM backers.

[thelogman] 05/12/2024 07:07

8.5 million to be raised at 10.5 p per share ooucn

[thelogman] 05/12/2024 07:04

11p coming sooner than I thought.Watch this space

[torquayfan] 05/12/2024 06:52

Yes Chilltime. And as the research progresses and Genmab look at a potential total tab of $1.2 billion under the existing two agreements, a platform buyout might perhaps look very attractive. Surely Scancell's BoD would give a mighty discount to get a major wad in hand, (such as $500 million).

I can visualise Prof. Lindy doing cartwheels at the thought !

All good fun.